Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCP-Tacro vs Azathioprine in Autoimmune Hepatitis
NCT00608894Phase 2Terminated
- Sponsor
- Veloxis Pharmaceuticals
- Start
- Dec 2007
- Primary completion
- Apr 2009
- Modality
- RNA-Targeting Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, open-label trial of Envarsus XR in autoimmune hepatitis (AIH) (2 arms), sponsored by Veloxis Pharmaceuticals. Primary endpoint: Biochemical Remission of AIH at 6 months. Started Dec 2007; status: terminated.
02
Drugs
Envarsus XR
03
Conditions
autoimmune hepatitis (AIH)
Beyond the preview
Go deeper on NCT00608894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00608894.